Combatting Viruses Wth RNA-Targeted CRISPR
Dr. David S. Weiss and Dr. Arash Grakoui, faculty members in IMP and MMG, are featured in an article in The Scientist for their work with RNA-Targeted CRISPR. The list of potential uses for the CRISPR/Cas system grows longer by the day. Now fighting viruses may soon be added to that list, according to their study published in PNAS.
Weiss, Grakoui, and their colleagues used a version of the Cas9 enzyme from the bacteria Francisella novicida to bind hepatitis C virus (HCV) RNA and prevent the pathogen from replicating inside human cells.
Click here to read the full article in The Scientist.